Tag: Soma

First approved by the FDA in 1959, Soma (carisoprodol) is a prescription muscle relaxant used as a short-term treatment for acute, painful musculoskeletal conditions. It is intended to be used alongside rest, physical therapy, and other supportive measures, and not as a standalone solution.

Carisoprodol is typically prescribed for only two to three weeks, as acute musculoskeletal pain is usually short-term. This article explores what is carisoprodol prescribed for, detailing its role as a short-term muscle relaxant used alongside rest and physical therapy. It also discusses the risks associated with this Schedule IV controlled substance.

According to an analysis of multiple studies, there is no single muscle relaxer definitively proven to be “the strongest” across the board, making the question, **Is Flexeril the strongest muscle relaxer?**, more complicated than it appears. The effectiveness of cyclobenzaprine (Flexeril) and other muscle relaxants can vary significantly depending on the individual, the condition, and the specific symptoms being treated.

According to the 2023 National Survey on Drug Use and Health, approximately 158,000 people aged 12 or older misused carisoprodol [1.2.3]. This raises a common question: **is carisoprodol considered a narcotic?** While it's a muscle relaxant, its potential for abuse leads to confusion about its classification [1.2.2].

The Drug Enforcement Administration (DEA) classified the prescription medication Soma as a Schedule IV controlled substance in 2012 due to its potential for abuse and dependence. Given its modern pharmaceutical reality, the answer to the question, "Is Soma a mushroom?" is definitively no, though confusion stems from an entirely separate, ancient historical context.

According to 2023 data from the National Survey on Drug Use and Health, approximately 671,000 people aged 12 or older used Soma [1.11.1]. A common question is, is there codeine in Soma? The answer depends on the specific formulation prescribed.

According to the 2023 National Survey on Drug Use and Health, approximately 158,000 people in the U.S. aged 12 or older misused carisoprodol [1.8.1]. While abused for its sedative effects, a key question remains: **is Soma a psychedelic?** The answer is no; it belongs to a different drug class entirely.

In 2008, the European Medicines Agency (EMA) recommended suspending the marketing of carisoprodol-containing products throughout Europe after a review found its risks outweighed its benefits. This marked a significant turn for the muscle relaxant and provides important context for understanding why was carisoprodol discontinued in many regions and reclassified in others.

While the standard muscle relaxant Soma (carisoprodol) does not contain codeine, a discontinued product known as Soma Compound with Codeine *did* feature this opioid. This fact addresses a common point of confusion regarding the active ingredients in Somas.

Carisoprodol, commonly sold under the brand name Soma, is a prescription skeletal muscle relaxant that acts on the central nervous system to provide short-term relief from acute, painful musculoskeletal conditions. First approved in the United States in 1959, the drug is now a Schedule IV controlled substance due to its potential for abuse and dependence.